An observational study in Surgical Approach, Child and Oesophageal Atresia, sponsored by University Hospital, Angers. Not yet recruiting at 11 sites in France. Open to participants aged 6 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by University Hospital, Angers · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Esophageal Atresia with a site in France — 5 open to participants now, 5 under way, none of them phase 3. Esophageal Atresia · France.
Among the 11 studies in Esophageal Atresia with a site in France, this one is the only one that started in 2026, is one of 7 observational ones, and was the 11th registered.
37 studies on the registry are indexed under Esophageal Atresia; 12 are open to participants now.
Browse Esophageal Atresia studies →5 of the 11 studies in Esophageal Atresia with a site in France are open now. Recruiting first, the newest first:
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18–30
University Hospital, Lille · Sites in France
Ages 2 mo–3 mo
University Hospital, Lille · Sites in France, Martinique, Réunion
Ages 13–14
University Hospital, Lille · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 10 Esophageal Atresia studies recruiting now, 2 (20%) set no upper age limit and 8 (80%) stop at 75 or younger; 8 take children under 18; 1 takes healthy volunteers.
This study: 6 Years to 10 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2026.
This study's planned enrollment of 360 is above the median of 50 across 19 observational studies indexed under Esophageal Atresia.
Median enrollment 23 across the 4 interventional studies, 300 across the 7 observational. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 11 has an industry lead sponsor. The 4 most frequent:
University Hospital, Angers is the lead sponsor of 480 studies on the registry; 122 are open to participants now.
University Hospital, Angers has 2 studies filed under Esophageal Atresia — fewer than ten, so there is no comparison to draw.
2 of the studies in Esophageal Atresia with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04522193University Hospital, LilleDumping Syndrome and Esophageal Atresia | 2026-11 |
| NCT04911036University Hospital, LilleStudy of the Effect of the Time of Diagnosis (Antenatal vs. Postnatal) on the Post-traumatic Reactions of Parents of Children Undergoing Oesophageal Atresia Surgery " | 2027-05 |
Add all 2 to your calendar (.ics) → With an account.
Among the 11 studies in Esophageal Atresia with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Children born with esophageal atresia need surgery shortly after birth. For many years, the standard operation was a thoracotomy, an opening in the chest that can sometimes lead to changes in the shape of the chest wall. Although these changes are visible on X rays, doctors still do not fully understand how much they affect breathing later in childhood. A newer, less invasive technique called thoracoscopy uses small incisions and appears to cause fewer chest deformities, but its impact on lung function has not yet been clearly established.
This study aims to compare the breathing capacity of children aged 6 to 9 who were operated on using either thoracotomy or thoracoscopy. The main question is whether one group is more likely to develop restrictive lung syndrome, a condition in which the lungs cannot expand normally. To answer this, the study relies on lung function tests and chest X rays performed during routine follow up visits.
Beyond this primary goal, the study also examines other possible breathing problems, the presence of chest wall abnormalities, and factors that might influence lung health, such as nutrition, physical activity, associated malformations, and overall quality of life.
A total of at least 360 children across France will participate. They are identified through national registries and invited during scheduled follow up consultations.
Eligible patients in both groups are mainly identified through the national esophageal atresia registry (RENATO, CRACMO, CHU Lille).
For thoracoscopy group:
Inclusion Criteria:
Exclusion Criteria:
Inclusion Criteria :
--Child operated on by thoracotomy for type 3 AO (excluding long gap) according to the Ladd classification
Exclusion Criteria:
For each patient who underwent thoracoscopic surgery included in the study, two patients who had thoracotomy, matched according to known or suspected confounding factors for restrictive syndromes from the RestriMIS1 (NCT04136795) study**, will be included.
*It's possible that some children had multiple consecutive surgeries. In those cases, if one of the procedures was a thoracotomy, the children will be classified in the thoracotomy group (the more major surgery).
**Prematurity, birth weight, presence of tracheomalacia, and GERD during the neonatal period (clinically and/or on additional tests)
minimally invasive surgical approach
conventionnal surgical approach
to assess the presence of a restrictive lung syndrome in patients with type 3 esophageal atresia (EA) depending on the type of surgical approach used (conventional or minimally invasive).
Rate of restrictive syndrome according to the type of surgical approach (conventional or minimally invasive), defined by spirometry data: FEV1/FVC \> -1.64 Z-score and FVC \< -1.64 Z-score, according to the ATS/ERS-GLI (American Thoracic Society \& European Respiratory Society - Global Lung Initiative) recommendations published in 2012 (Quanjer) and reviewed en 2022.
Time frame: Lung function tests can be done up to 2 years after the multidisciplinary consultation (Visit 0)
to evaluate the importance of restrictive syndrome
The importance of restrictive syndrome is classified into 3 levels: mild restrictive syndrome \[-1.64 \> z-score ≥ -2.5\], moderate \[-2.5 \> z-score ≥ -4.0\], or severe \[-4.0 \> z-score\]).
Time frame: importance of restrictive syndrome can be evaluated up to 2 years after the multidisciplinary consultation (visit 0)
Looking for other respiratory parameters
Other respiratory changes are examined by measuring other respiratory parameters (forced vital capacity, FEF 25-75, Tiffeneau ratio, reversibility), which help highlight obstructive or mixed syndromes (FEV1/FVC \< -1.64 and FVC \< -1.64 z-score) when present
Time frame: the link between chest skeletal abnormalities found on chest X-rays and lung impact can be evaluated up to 2 years after the multidisciplinary consultation
to assess the link between chest skeletal abnormalities found on chest X-rays and lung impact
The following factors are considered when estimating the risk of association with or without a restrictive syndrome (history data like prematurity or types of malformations associated with AO III, surgical and medical care data in the neonatal period and childhood, growth data at one year and at 6-10 years), lung care, physical activity, the PedsQL score (for children aged 6 to 10), and responses to the EA-QoL questionnaire (for children aged 8 to 10).
Time frame: until spirometry is completed, within a maximum period of 2 years
rate of postoperative complications and any necessary reoperations
The rate of postoperative complications is assessed by type of surgery as well as any necessary follow-up surgeries.
Time frame: up to 2 years after the multidisciplinary consultation
Respiratory-related quality of life during childhood
It will be estimated through both need for lung care, physical activity, PedsQL score (for children aged 6 to 10), and EA-QoL questionnaire (for children aged 8 to 10).
Time frame: up to 2 years after the multidisciplinary consultation
to assess the existence of a cause-and-effect link between the restrictive syndrome and the surgical technique used
The acceptability of the existence of a causal link is assessed using sensitivity analysis, which estimates how robust the results are while taking into account missing data and different clinical scenarios (including a per-protocol analysis in addition to the intention-to-treat analysis).
Time frame: through study completion, within a maximum of 24 months
to assess the mortality rate
The death rate for each surgery group will be described based on the follow-up in the study, that is, the date of the surgery (combined data for all patients in the registry).
Time frame: through study completion, an average 7 years
Looking for lung volumes variations
Lung volume variations will be measured by dynamic respiratory MRI data
Time frame: the link between chest skeletal abnormalities found on chest X-rays and MRI lung volumes can be evaluated up to 2 years after the multidisciplinary consultation
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Dec 2032, 72 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.